Sisu Pharma
Biotechnology Research
San Diego, California, United States
2 employees
- Employees
- 2
- Contacts
- 1
- Emails
- 1
Sisu Pharma Overview
- Headquarters
- San Diego, California, United States
- Website
- sisupharma.com
- Industry
- Biotechnology Research
- Employees
- 2
- Founded
- 2019
- Funding
- 1.7M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Sisu Pharma
Sisu Pharma exploits cellular stress by directly targeting HSF1, the Master Regulator of the heat shock response. Our HSF1 targeting platform (HI-LiTe) is being developed to deliver selective HSF1 degraders for oncology and therapies for use in neurodegenerative conditions and infection, providing a unique approach to treating these devastating diseases.
Sisu Pharma Contact Details
- People in AeroLeads
- 1
- With contact data
- 1
- Email contacts
- 1
- 100.0% coverage
Sisu Pharma Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Dennis J. Thiele | Co-founder and Chief Scientific Officer | Boston, Massachusetts, United States |
Email
|
Compare Similar Companies to Sisu Pharma
Adamed Laboratorios S.L.U.
Pharmaceutical Manufacturing
LSX - partnering for Life Science eXecutives
Information Services
Ten63 Therapeutics
Biotechnology Research
ARC Medical Inc.
Medical Equipment Manufacturing
Emerald BioVentures
Venture Capital And Private Equity Principals
PhenoVista
Biotechnology Research
Y Innovations
Venture Capital And Private Equity Principals
Meliora Therapeutics
Biotechnology Research
Harmonia Healthcare
Public Health
Cellective BioTherapy
Related company record